advertisement

Topcon

Azuara-Blanco A 31

Showing records 1 to 25 | Display all abstracts from Azuara-Blanco A

100244 Predictors of long-term intraocular pressure control after lens extraction in primary angle closure glaucoma: results from the EAGLE trial
Mitchell WG
British Journal of Ophthalmology 2023; 107: 1072-1078
100535 How Can We Quantify and Compare Harm in Surgical Trials?
Protasio JN
American Journal of Ophthalmology 2022; 241: 64-70
99518 A Review to Populate A Proposed Cost-Effectiveness Analysis of Glaucoma Screening in Sub-Saharan Africa
Olawoye O
Ophthalmic Epidemiology 2022; 29: 328-338
100646 Adverse Effects and Safety in Glaucoma Patients: Agreement on Clinical Trial Outcomes for Reports on Eye Drops (ASGARD)-A Delphi Consensus Statement
Thein AS; Hedengran A
American Journal of Ophthalmology 2022; 241: 190-197
99518 A Review to Populate A Proposed Cost-Effectiveness Analysis of Glaucoma Screening in Sub-Saharan Africa
Azuara-Blanco A
Ophthalmic Epidemiology 2022; 29: 328-338
100535 How Can We Quantify and Compare Harm in Surgical Trials?
King A
American Journal of Ophthalmology 2022; 241: 64-70
100244 Predictors of long-term intraocular pressure control after lens extraction in primary angle closure glaucoma: results from the EAGLE trial
Azuara-Blanco A
British Journal of Ophthalmology 2023; 107: 1072-1078
99518 A Review to Populate A Proposed Cost-Effectiveness Analysis of Glaucoma Screening in Sub-Saharan Africa
Chan VF
Ophthalmic Epidemiology 2022; 29: 328-338
100646 Adverse Effects and Safety in Glaucoma Patients: Agreement on Clinical Trial Outcomes for Reports on Eye Drops (ASGARD)-A Delphi Consensus Statement
Azuara-Blanco A
American Journal of Ophthalmology 2022; 241: 190-197
100244 Predictors of long-term intraocular pressure control after lens extraction in primary angle closure glaucoma: results from the EAGLE trial
Foster PJ
British Journal of Ophthalmology 2023; 107: 1072-1078
100535 How Can We Quantify and Compare Harm in Surgical Trials?
Pasquale LR; Barton K
American Journal of Ophthalmology 2022; 241: 64-70
99518 A Review to Populate A Proposed Cost-Effectiveness Analysis of Glaucoma Screening in Sub-Saharan Africa
Piyasena P
Ophthalmic Epidemiology 2022; 29: 328-338
100646 Adverse Effects and Safety in Glaucoma Patients: Agreement on Clinical Trial Outcomes for Reports on Eye Drops (ASGARD)-A Delphi Consensus Statement
Arita R
American Journal of Ophthalmology 2022; 241: 190-197
100244 Predictors of long-term intraocular pressure control after lens extraction in primary angle closure glaucoma: results from the EAGLE trial
Halawa O; Burr J
British Journal of Ophthalmology 2023; 107: 1072-1078
100646 Adverse Effects and Safety in Glaucoma Patients: Agreement on Clinical Trial Outcomes for Reports on Eye Drops (ASGARD)-A Delphi Consensus Statement
Cvenkel B
American Journal of Ophthalmology 2022; 241: 190-197
99518 A Review to Populate A Proposed Cost-Effectiveness Analysis of Glaucoma Screening in Sub-Saharan Africa
Crealey GE
Ophthalmic Epidemiology 2022; 29: 328-338
100535 How Can We Quantify and Compare Harm in Surgical Trials?
Bonnar J; Qureshi R
American Journal of Ophthalmology 2022; 241: 64-70
100244 Predictors of long-term intraocular pressure control after lens extraction in primary angle closure glaucoma: results from the EAGLE trial
Ramsay CR
British Journal of Ophthalmology 2023; 107: 1072-1078
99518 A Review to Populate A Proposed Cost-Effectiveness Analysis of Glaucoma Screening in Sub-Saharan Africa
O'Neill C
Ophthalmic Epidemiology 2022; 29: 328-338
100646 Adverse Effects and Safety in Glaucoma Patients: Agreement on Clinical Trial Outcomes for Reports on Eye Drops (ASGARD)-A Delphi Consensus Statement
Gazzard G; Heegaard S
American Journal of Ophthalmology 2022; 241: 190-197
100535 How Can We Quantify and Compare Harm in Surgical Trials?
Virgili G
American Journal of Ophthalmology 2022; 241: 64-70
100244 Predictors of long-term intraocular pressure control after lens extraction in primary angle closure glaucoma: results from the EAGLE trial
Cooper D
British Journal of Ophthalmology 2023; 107: 1072-1078
99518 A Review to Populate A Proposed Cost-Effectiveness Analysis of Glaucoma Screening in Sub-Saharan Africa
Congdon N
Ophthalmic Epidemiology 2022; 29: 328-338
100535 How Can We Quantify and Compare Harm in Surgical Trials?
Azuara-Blanco A
American Journal of Ophthalmology 2022; 241: 64-70
100646 Adverse Effects and Safety in Glaucoma Patients: Agreement on Clinical Trial Outcomes for Reports on Eye Drops (ASGARD)-A Delphi Consensus Statement
de Paiva CS
American Journal of Ophthalmology 2022; 241: 190-197

Issue 23-1

Change Issue


advertisement

Oculus